Table 2.
Baseline and disease characteristics
| Characteristics | Patients (n = 83) | Caregivers (n = 83) |
|---|---|---|
| No. (%) | No. (%) | |
| Age (years) | ||
| Median | 49 | 50 |
| Range | 23–80 | 23–78 |
| Sex | ||
| Male | 52 (63) | 22 (27) |
| Female | 31 (37) | 60 (73) |
| Race | ||
| White | 68 (82) | – |
| Asian | 4 (5) | – |
| Other or N/A | 11 (13) | – |
| Education | ||
| High school or less | 19 (23) | 19 (23) |
| Associate or bachelor’s degree | 34 (41) | 38 (46) |
| Graduate/professional | 30 (36) | 23 (28) |
| Household income | ||
| Under $75,000 | 30 (36) | 18 (22) |
| $75,001–$125,000 | 21 (25) | 25 (30) |
| $125,001–$200,000 | 19 (23) | 19 (23) |
| Over $200,000 | 11 (13) | 13 (16) |
| KPS | ||
| Median | 90 | 90 |
| Range | 60–100 | 60–100 |
| Tumor grade (most recent surgery) | ||
| II | 22 (26) | 18 (22) |
| III | 25 (30) | 24 (29) |
| IV | 33 (40) | 41 (49) |
| Unknown or N/A | 3 (4) | |
| Prognosis status* | ||
| Stable disease (SD) | 75 (90) | 72 (87) |
| Progressive disease (PD) | 8 (10) | 11 (13) |
| Receiving chemotherapy at time of form completion | ||
| Yes | 32 (39) | 37 (45) |
| No | 51 (61) | 46 (55) |
| Time from initial diagnosis (years) | ||
| Median | 1.6 | 0.8 |
| Range | 0.02–28 | 0.02–14.8 |
– data not collected
*Based on most recent clinic visit